Silver Lake Advisory’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.73M | Sell |
28,498
-1,602
| -5% | -$93.4K | 0.69% | 47 |
|
|
2025
Q4 | $1.62M | Sell |
30,100
-335
| -1% | -$16.1K | 0.63% | 50 |
|
|
2025
Q3 | $1.37M | Sell |
30,435
-814
| -3% | -$38K | 0.55% | 54 |
|
|
2025
Q2 | $1.45M | Buy |
31,249
+1,024
| +3% | +$50.3K | 0.62% | 55 |
|
|
2025
Q1 | $1.84M | Buy |
30,225
+272
| +0.9% | +$15.9K | 0.8% | 48 |
|
|
2024
Q4 | $1.69M | Buy |
29,953
+282
| +1% | +$15.8K | 0.75% | 49 |
|
|
2024
Q3 | $1.54M | Buy |
29,671
+321
| +1% | +$15.1K | 0.63% | 54 |
|
|
2024
Q2 | $1.22M | Buy |
29,350
+344
| +1% | +$15.4K | 0.55% | 55 |
|
|
2024
Q1 | $1.57M | Buy |
29,006
+124
| +0.4% | +$6.32K | 0.7% | 47 |
|
|
2023
Q4 | $1.48M | Sell |
28,882
-941
| -3% | -$49.4K | 0.83% | 43 |
|
|
2023
Q3 | $1.73M | Sell |
29,823
-325
| -1% | -$19.9K | 1.07% | 39 |
|
|
2023
Q2 | $1.93M | Sell |
30,148
-1,222
| -4% | -$81.9K | 1.03% | 39 |
|
|
2023
Q1 | $2.17M | Buy |
31,370
+135
| +0.4% | +$9.52K | 1.21% | 34 |
|
|
2022
Q4 | $2.25M | Buy |
31,235
+69
| +0.2% | +$5.2K | 1.37% | 34 |
|
|
2022
Q3 | $2.22M | Buy |
31,166
+71
| +0.2% | +$5.15K | 1.3% | 34 |
|
|
2022
Q2 | $2.39M | Buy |
31,095
+71
| +0.2% | +$5.41K | 1.31% | 34 |
|
|
2022
Q1 | $2.27M | Buy |
31,024
+81
| +0.3% | +$5.44K | 1.08% | 39 |
|
|
2021
Q4 | $1.93M | Buy |
30,943
+80
| +0.3% | +$4.69K | 0.89% | 43 |
|
|
2021
Q3 | $1.83M | Hold |
30,863
| – | – | 0.9% | 43 |
|
|
2021
Q2 | $2.14M | Sell |
30,863
-874
| -3% | -$57K | 1.02% | 42 |
|
|
2021
Q1 | $2M | Buy |
31,737
+1,185
| +4% | +$73.7K | 1.02% | 43 |
|
|
2020
Q4 | $1.9M | Buy |
30,552
+68
| +0.2% | +$4.18K | 1.04% | 41 |
|
|
2020
Q3 | $1.84M | Sell |
30,484
-1,342
| -4% | -$80.8K | 1.13% | 39 |
|
|
2020
Q2 | $1.87M | Buy |
31,826
+148
| +0.5% | +$8.85K | 1.2% | 38 |
|
|
2020
Q1 | $1.77M | Sell |
31,678
-599
| -2% | -$36.6K | 1.3% | 36 |
|
|
2019
Q4 | $2.07M | Buy |
32,277
+106
| +0.3% | +$6.07K | 1.25% | 35 |
|
|
2019
Q3 | $1.63M | Buy |
32,171
+727
| +2% | +$34.2K | 1.05% | 38 |
|
|
2019
Q2 | $1.43M | Sell |
31,444
-378
| -1% | -$17.6K | 0.94% | 40 |
|
|
2019
Q1 | $1.52M | Buy |
31,822
+207
| +0.7% | +$10.3K | 1.02% | 41 |
|
|
2018
Q4 | $1.64M | Buy |
31,615
+299
| +1% | +$16.1K | 1.22% | 37 |
|
|
2018
Q3 | $1.94M | Buy |
31,316
+648
| +2% | +$38.5K | 1.18% | 36 |
|
|
2018
Q2 | $1.71M | Sell |
30,668
-280
| -0.9% | -$15.1K | 1.36% | 33 |
|
|
2018
Q1 | $1.96M | Buy |
30,948
+165
| +0.5% | +$10.6K | 1.45% | 29 |
|
|
2017
Q4 | $1.89M | Buy |
30,783
+150
| +0.5% | +$9.38K | 1.34% | 31 |
|
|
2017
Q3 | $1.95M | Sell |
30,633
-535
| -2% | -$31.2K | 1.49% | 29 |
|
|
2017
Q2 | $1.74M | Buy |
31,168
+163
| +0.5% | +$8.87K | 1.29% | 35 |
|
|
2017
Q1 | $1.69M | Sell |
31,005
-1,175
| -4% | -$64.4K | 1.27% | 34 |
|
|
2016
Q4 | $1.88M | Buy |
32,180
+56
| +0.2% | +$3.06K | 1.45% | 31 |
|
|
2016
Q3 | $1.73M | Buy |
32,124
+105
| +0.3% | +$6.75K | 1.29% | 35 |
|
|
2016
Q2 | $2.35M | Buy |
32,019
+129
| +0.4% | +$9.12K | 1.76% | 26 |
|
|
2016
Q1 | $2.04M | Sell |
31,890
-39,866
| -56% | -$2.51M | 1.73% | 29 |
|
|
2015
Q4 | $4.94M | Sell |
71,756
-2,240
| -3% | -$148K | 4.41% | 2 |
|
|
2015
Q3 | $4.38M | Sell |
73,996
-451
| -0.6% | -$28.6K | 3.95% | 3 |
|
|
2015
Q2 | $4.95M | Sell |
74,447
-2,806
| -4% | -$185K | 4.02% | 2 |
|
|
2015
Q1 | $4.98M | Sell |
77,253
-2,241
| -3% | -$140K | 4.01% | 2 |
|
|
2014
Q4 | $4.69M | Sell |
79,494
-402
| -0.5% | -$22.7K | 3.81% | 3 |
|
|
2014
Q3 | $4.09M | Buy |
79,896
+2,917
| +4% | +$146K | 3.35% | 4 |
|
|
2014
Q2 | $3.78M | Buy |
76,979
+4,480
| +6% | +$221K | 3.13% | 5 |
|
|
2014
Q1 | $3.77M | Sell |
72,499
-4,729
| -6% | -$252K | 3.37% | 4 |
|
|
2013
Q4 | $4.11M | Buy |
+77,228
| New | +$3.93M | 3.49% | 2 |
|
Other funds holding BMY
VCM
VPM
Silver Lake Advisory's BMY Position: Q1 2026 in Review
Silver Lake Advisory reduced its Bristol-Myers Squibb (BMY) stake by 5.3% in Q1 2026, selling an estimated $93.4K and leaving 28,498 shares worth $1.73M. The position accounts for 0.69% of the portfolio, ranked #47.
Silver Lake Advisory first reported a position in BMY in Q4 2013 and has held it in 50 quarters since. The position peaked at $4.98M in Q1 2015. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Silver Lake Advisory held 28,498 shares of Bristol-Myers Squibb worth $1.73M as of Q1 2026.
- Silver Lake Advisory sold 1,602 Bristol-Myers Squibb shares in Q1 2026, an estimated $93.4K.
- Bristol-Myers Squibb made up 0.69% of Silver Lake Advisory's portfolio in Q1 2026, its #47 holding.
- Silver Lake Advisory first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 50 quarters since.
- Silver Lake Advisory's Bristol-Myers Squibb position peaked at $4.98M in Q1 2015.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Silver Lake Advisory's 13F filing for Q1 2026, filed 27 Apr 2026.